Verheijen JH - Search Results

1

Identification of a reversible inhibitor of plasminogen activators in blood plasma.

Kluft C, Jie AF, Sprengers ED, Verheijen JH. Kluft C, et al. Among authors: verheijen jh. FEBS Lett. 1985 Oct 14;190(2):315-8. doi: 10.1016/0014-5793(85)81309-0. FEBS Lett. 1985. PMID: 3930295 Free article.

2

Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).

Kluft C, Jie AF, Rijken DC, Verheijen JH. Kluft C, et al. Among authors: verheijen jh. Thromb Haemost. 1988 Apr 8;59(2):329-32. Thromb Haemost. 1988. PMID: 3133814

3

The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma.

Kluft C, Verheijen JH, Jie AF, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO. Kluft C, et al. Among authors: verheijen jh. Scand J Clin Lab Invest. 1985 Nov;45(7):605-10. doi: 10.3109/00365518509155267. Scand J Clin Lab Invest. 1985. PMID: 3934744

4

Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.

Verheijen JH, Chang GT, Kluft C. Verheijen JH, et al. Thromb Haemost. 1984 Jul 29;51(3):392-5. Thromb Haemost. 1984. PMID: 6437006

5

Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.

Verheijen JH, Rijken DC, Chang GT, Preston FE, Kluft C. Verheijen JH, et al. Thromb Haemost. 1984 Jul 29;51(3):396-7. Thromb Haemost. 1984. PMID: 6437007

6

Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor.

D'Angelo A, Kluft C, Verheijen JH, Rijken DC, Mozzi E, Mannucci PM. D'Angelo A, et al. Among authors: verheijen jh. Eur J Clin Invest. 1985 Dec;15(6):308-12. doi: 10.1111/j.1365-2362.1985.tb00277.x. Eur J Clin Invest. 1985. PMID: 3938400

7

Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.

Sprengers ED, Verheijen JH, Van Hinsbergh VW, Emeis JJ. Sprengers ED, et al. Among authors: verheijen jh. Biochim Biophys Acta. 1984 Sep 28;801(2):163-70. doi: 10.1016/0304-4165(84)90063-1. Biochim Biophys Acta. 1984. PMID: 6541058

8

Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity.

Sue-Ling HM, Davies JA, Prentice CR, Verheijen JH, Kluft C. Sue-Ling HM, et al. Among authors: verheijen jh. Thromb Haemost. 1985 Feb 18;53(1):141-2. Thromb Haemost. 1985. PMID: 3873118

9

Assignment of the human tissue-type plasminogen activator gene (PLAT) to chromosome 8.

Verheijen JH, Visse R, Wijnen JT, Chang GT, Kluft C, Meera Khan P. Verheijen JH, et al. Hum Genet. 1986 Feb;72(2):153-6. doi: 10.1007/BF00283935. Hum Genet. 1986. PMID: 3002960

10

Quantification of tissue-type plasminogen activator (t-PA) mRNA in human endothelial-cell cultures by hybridization with a t-PA cDNA probe.

van Zonneveld AJ, Chang GT, van den Berg J, Kooistra T, Verheijen JH, Pannekoek H, Kluft C. van Zonneveld AJ, et al. Among authors: verheijen jh. Biochem J. 1986 Apr 15;235(2):385-90. doi: 10.1042/bj2350385. Biochem J. 1986. PMID: 3091007 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters